The incidence of ototoxicity in child malignancy cases that received carboplatin therapy with otoacoustic emission (OAE) examination

1st Physics and Technologies in Medicine and Dentistry Symposium

物理学;医药卫生

Wibowo, J.K.^1 ; Zizlavsky, S.^1 ; Suwento, R.^1 ; Sjakti, H.A.^1 ; Prihartono, J.^1

Department of Ear Nose Throat, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia^1

关键词: Carboplatin;    Carboxylato;    Cross-sectional design;    Cytotoxic drugs;    General hospitals;    Ototoxicity;    Risk factors;    Second generation;   

Others  :  https://iopscience.iop.org/article/10.1088/1742-6596/884/1/012126/pdf
DOI  :  10.1088/1742-6596/884/1/012126

学科分类：卫生学

来源: IOP

【 摘 要 】

Malignancy is a significant public health problem, both globally and in Indonesia. Chemotherapy is one of the modality in malignancy cases. Carboplatin (cis-diammine-cyclobutanedi-carboxylato platinum) is a second-generation platinum compound that has often been used in the management of cases of malignancies. On the other hand, side effects of cytotoxic drugs need to be considered, especially ototoxic effects. Ototoxicity is dysfunction and damage to the structure of the inner ear that has been caused by drugs or other certain chemicals. The aim of this study is to assess ototoxic effects due to the influence of carboplatin in the cases of children with malignancy. This study uses a serial cross-sectional design to evaluate otoacoustic emission (OAE) signal-to-noise ratio (SNR) change as a result of ototoxic effects and risk factors due to the use of ototoxic carboplatin in the Division of Hematology-Oncology of the Department of Pediatrics at Cipto Mangunkusumo General Hospital in Jakarta, where two of 52 studies' subjects experienced ototoxicity. In the group were receiving chemotherapy, two (5%) of the 40 subjects has experienced ototoxic events characterized by SNR values less than six, whereas SNR values were not less than six in the group that had not received chemotherapy. Risk factors such as gender, age, carboplatin dose, and cycles of chemotherapy did not have a statistically significant relationship to ototoxity.